Source:http://linkedlifedata.com/resource/pubmed/id/17493241
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
6
|
| pubmed:dateCreated |
2007-5-11
|
| pubmed:abstractText |
A dualistic pathway of ovarian serous carcinogenesis is now well established whereby high-grade serous carcinoma and low-grade serous carcinoma represent two distinct tumour types with a different underlying pathogenesis. The aim of this study was to compare expression of p16 INK4A (p16) in these two tumour types. We also included cases of serous borderline tumour, since these are considered to represent a precursor lesion of low-grade serous carcinoma.
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
May
|
| pubmed:issn |
0309-0167
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
50
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
773-9
|
| pubmed:meshHeading |
pubmed-meshheading:17493241-Cyclin-Dependent Kinase Inhibitor p16,
pubmed-meshheading:17493241-Disease Progression,
pubmed-meshheading:17493241-Female,
pubmed-meshheading:17493241-Gene Expression Regulation, Neoplastic,
pubmed-meshheading:17493241-Humans,
pubmed-meshheading:17493241-Neoplasm Staging,
pubmed-meshheading:17493241-Neoplasms, Cystic, Mucinous, and Serous,
pubmed-meshheading:17493241-Ovarian Neoplasms,
pubmed-meshheading:17493241-Ovary,
pubmed-meshheading:17493241-Prognosis,
pubmed-meshheading:17493241-Severity of Illness Index
|
| pubmed:year |
2007
|
| pubmed:articleTitle |
High-grade ovarian serous carcinoma exhibits significantly higher p16 expression than low-grade serous carcinoma and serous borderline tumour.
|
| pubmed:affiliation |
Department of Pathology, Royal Group of Hospitals Trust, Grosvenor Road, Belfast, Northern Ireland, UK.
|
| pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't
|